Bearing Point Capital, LLC Astrazeneca PLC Transaction History
Bearing Point Capital, LLC
- $480 Billion
- Q4 2024
A detailed history of Bearing Point Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Bearing Point Capital, LLC holds 11,407 shares of AZN stock, worth $841,950. This represents 0.16% of its overall portfolio holdings.
Number of Shares
11,407Holding current value
$841,950% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,355Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.45 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.03 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.77 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...